No recent analyst price targets found for SHILPAMED.NS.
Latest News for SHILPAMED.NS

SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
/PRNewswire/ -- SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated
PRNewsWire • Feb 25, 2026

SteinCares und Shilpa Biologicals schließen Lizenzvereinbarung zur Erweiterung des Zugangs zu Biosimilars in ganz Lateinamerika
/PRNewswire/ -- SteinCares, ein führendes Unternehmen im Bereich der Spezialmedizin in Lateinamerika, und Shilpa Biologicals Pvt. Ltd. (SBPL), eine vollständig
PRNewsWire • Feb 25, 2026

SteinCares et Shilpa Biologicals concluent un accord de licence pour élargir l'accès aux biosimilaires en Amérique latine
/PRNewswire/ -- SteinCares, une société leader dans le domaine des soins médicaux implantée en Amérique latine, et Shilpa Biologicals Pvt. Ltd. (SBPL), une
PRNewsWire • Feb 25, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SHILPAMED.NS.
Senate Trading
No Senate trades found for SHILPAMED.NS.
U.S. House Trading
No House trades found for SHILPAMED.NS.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
